The Paracelsus Medical University is a private university located in Salzburg municipality, Austria and Nuremberg, Germany.

During the past decade, Paracelsus Medical University Salzburg - Oncology conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paracelsus Medical University Salzburg - Oncology" #1 sponsor was "Austrian Breast & Colorectal Cancer Study Group" with 11 trials, followed by "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 4 trials sponsored, "Medical University Innsbruck" with 2 trials sponsored, "Medical University of Vienna" with 2 trials sponsored and "Merck KGaA, Darmstadt, Germany" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paracelsus Medical University Salzburg - Oncology" #1 collaborator was "Hoffmann-La Roche" with 6 trials as a collaborator, "Amgen" with 3 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Paracelsus Medical University" with 2 trials as a collaborator and "Assign Data Management and Biostatistics GmbH" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Paracelsus Medical University Salzburg - Oncology" are "Breast Cancer" (4 trials), "Multiple Sclerosis" (3 trials), "Rectal Cancer" (3 trials), "Brain Aneurysm" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Paracelsus Medical University Salzburg - Oncology" in a lesser frequency.

Most popular intervention types in "Paracelsus Medical University Salzburg - Oncology" are "Drug" (18 trials), "Device" (3 trials), "Procedure" (2 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (3 trials), "Mavenclad®" (3 trials), "Oxaliplatin" (2 trials), "5-fluorouracil, levamisol, interferon" (1 trials) and "CPI-613 + High Dose Cytarabine and Mitoxantrone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Paracelsus Medical University Salzburg - Oncology" are 24 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Paracelsus Medical University Salzburg - Oncology". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Paracelsus Medical University Salzburg - Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Paracelsus Medical University Salzburg - Oncology, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".